Stay updated on Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial
Sign up to get notified when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.
Latest updates to the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated to v3.3.2. The previous revision v3.2.0 was removed.SummaryDifference0.1%
- Check28 days agoChange DetectedRemoved a general government funding and operating status notice from the page, which previously informed users that information may not be up to date and that the NIH Clinical Center is open. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check42 days agoChange DetectedNo notable additions or deletions were detected; the page content and layout appear unchanged. The study details, eligibility criteria, and locations remain the same as in the previous view.SummaryDifference0.3%
- Check71 days agoChange DetectedThe page now explicitly notes potential delays due to funding, confirms the NIH Clinical Center is open, directs users to cc.nih.gov and opm.gov for status, and indicates a version upgrade to v3.2.0.SummaryDifference3%
- Check78 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%
- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%
Stay in the know with updates to Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.